TABLE 3.
Median | 25 quadrantile | 75th percentile | p‐Value | ||
---|---|---|---|---|---|
Semen volume (ml) | T0‐T1 | 0 | −0.94 | −0.45 | 0.29 |
T0‐T2 | 0.2 | −0.4 | −0.8 | 0.16 | |
T0‐T3 | −0.05 | −0.5 | −0.52 | 0.63 | |
Sperm concentration (X 106/ml) | T0‐T1 | 12.5 | −10 | 27.25 | 0.09 |
T0‐T2 | 12 | −8 | 31 | 0.02 | |
T0‐T3 | 3.5 | −15.5 | 27.5 | 0.4 | |
Sperm motility (%) 3 , 4 | T0‐T1 | −5 | −9.25 | 5 | 0.62 |
T0‐T2 | 5 | −6 | 10 | 0.59 | |
T0‐T3 | 0 | −5 | 11 | 0.44 | |
Total motile count (X 106) | T0‐T1 | 9.8 | −23.2 | −24.1 | 0.36 |
T0‐T2 | 31.2 | 2.5 | 57.8 | 0.002 | |
T0‐T3 | 4.48 | −18.3 | 48.6 | 0.39 |
T0 – pre‐vaccination baseline control; T1, T2 and T3 – short, intermediate and long‐term evaluations after 15–45, 75–125 and over 145 days after the vaccination date, respectively.
Samples sizes: 28, 29 and 22 SD for T1, T2 and T3 comparisons, respectively.
Progressive and non‐progressive.
Wilcoxon for all variables except motility, which was compared by t‐test.